APD
42
-2
WYNN
34
-3
ICE
64
-5
FRT
41
-2
DLTR
31
3
FLS
46
-7
PX
52
-3
GRMN
50
-2
MRK
53
3
AVY
54
-14
MNST
52
2
EBAY
50
-3
NTRS
47
-2
SWN
70
3
SBUX
41
-3
MSI
69
-3
PSX
42
3
TRIP
60
3
NEE
52
-2
HPQ
62
2
APD
42
-2
WYNN
34
-3
ICE
64
-5
FRT
41
-2
DLTR
31
3
FLS
46
-7
PX
52
-3
GRMN
50
-2
MRK
53
3
AVY
54
-14
MNST
52
2
EBAY
50
-3
NTRS
47
-2
SWN
70
3
SBUX
41
-3
MSI
69
-3
PSX
42
3
TRIP
60
3
NEE
52
-2
HPQ
62
2
Financhill
Back

Purple Innovation Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
12

PRPL
Purple Innovation

Last Price:
1.07
Seasonality Move:
0.45%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.44
Seasonality Move:
5.7%
Sell
12
Purple Innovation (PRPL) is a Sell

Is Purple Innovation a Buy, Sell or Hold?

  • The current Purple Innovation [PRPL] share price is $1.05. The Score for PRPL is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • PRPL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPL Stock Price Chart

What is Purple Innovation's stock price today?

  • The Purple Innovation share price today is $1.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPL is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

PRPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 43.74 Sell
Chaikin Money Flow: -94818 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.03 - 1.21) Sell
Bollinger Bands (100): (1.02 - 1.42) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

PRPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.04 Buy
20-day SMA: 1.12 Sell
50-day SMA: 1.18 Sell
200-day SMA: 1.28 Sell
8-day EMA: 1.06 Sell
20-day EMA: 1.09 Sell
50-day EMA: 1.15 Sell
200-day EMA: 1.42 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Purple Innovation Earnings Growth & PRPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.05 per share, an increase this year of $0.19 per share, and an increase next year of $0.24 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Purple Innovation Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):